Local treatment for remaining cancer spots after first treatment
Part of Cancer clinical trials.
This trial tests whether a local treatment (like radiation or other targeted methods) can destroy the few remaining cancer spots that are still visible after your first treatment has worked. The goal is to delay or prevent the cancer from growing again.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are physically active and able to care for yourself (ECOG performance status 0 or 1).
- You have one of the listed cancer types, such as breast, lung, head and neck, stomach, esophagus, pancreas, anal, bladder, kidney, prostate, endometrial, cervical, colorectal, soft tissue sarcoma, or melanoma.
- You have received the standard first-line treatment for your advanced cancer (called OST) and it has been working – your cancer has not grown.
- You have been on that treatment for 3 to 6 months, and your cancer has a limited number of metastatic spots (called oligometastatic disease) that can be treated with local therapy.
- You have not had radiation therapy or other local treatments for your metastatic spots before starting your current treatment.
- Your cancer is not completely gone (no complete response) – there must be at least one spot that can be targeted.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving local treatments (like surgery or radiation) to cancer spots later—after starting immunotherapy or targeted therapy—helps people with stomach or esophageal cancer that has spread to a few places. It aims to improve outcomes by timing treatments carefully.
This trial tests whether continuing your current therapy after getting local treatment (like surgery or radiation) for a small area of cancer growth is safe and effective. It may help you keep the same treatment longer before switching to a new one.
This trial tests whether adding local treatments like radiation or surgery to standard immunotherapy can help people with lung cancer that has spread to a few spots. It aims to see if this combination improves control of the disease.
This study is for people with solid tumors that have spread to a few spots (5 or fewer) in the body. It tests whether using a focused treatment like radiation or ablation on those spots can help control the cancer long-term.
This trial tests whether using local treatments (like targeted radiation or ablation) on a few new spots of cancer can help people whose cancer is otherwise stable on their current treatment. It enrolls people with various solid tumors, such as breast, gynecologic, head & neck, sarcoma, or other types.
This trial tests whether adding targeted radiation or surgery to your regular osimertinib treatment can better control any remaining spots of lung cancer. It is for people with a specific EGFR mutation whose cancer has shrunk but left a few active sites.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.